Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 02 May 2017
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary) ; Gliclazide
- Indications Guttate psoriasis; Plaque psoriasis; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Apr 2016 Status changed from active, no longer recruiting to completed.
- 02 Dec 2015 Planned primary completion date changed from 1 Apr 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov.